Neuroprotective Effect of Trans-Resveratrol in Mild to Moderate Alzheimer Disease: A Randomized, Double-Blind Trial

ConclusionThese results indicate thattrans-resveratrol has potential neuroprotective roles in the treatment of moderate to mild AD and that its mechanism may involve a reduction in the accumulation and toxicity of A β in the brain of patients, thereby reducing neuroinflammation.Trial RegistrationChinese clinical trial registry: CTR20151780X.
Source: Neurology and Therapy - Category: Neurology Source Type: research